Seismic Therapeutic
Paras Doshi has a diverse work experience spanning from 2009 to 2022. In 2009, they were a Lab Member at the Cleveland Functional Electrical Stimulation Center. In 2010, they became a Co-Inventor/Co-Founder at Miach Medical Innovations. In 2011, they were an R&D Intern at ArthroCare Corporation and a Corporate Development Consultant at CardioInsight, Inc. In 2012, they were a Business Associate at ZS Associates. In 2018, they were an MBA Intern at Longitude Capital and a Business Development & Strategy MBA Intern at Regeneron Pharmaceuticals, Inc. From 2019 to 2022, they were a Senior Manager, Business Development at Regeneron and is currently the Director, Business Development at Seismic Therapeutic.
Paras Doshi attended Case Western Reserve University from 2008 to 2012, where they received a B.S.E. in Biomedical Engineering. Paras then attended Northwestern University - Kellogg School of Management from 2017 to 2019, where they earned a Master of Business Administration - MBA.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.